[
  {
    "ts": null,
    "headline": "Tracking Terry Smith's Fundsmith 13F Portfolio - Q2 2025 Update",
    "summary": "Read here for an in-depth analysis and insights on Fundsmith's $23.02B portfolio shift: new stakes, exits, and top positions like Meta and Microsoft.",
    "url": "https://finnhub.io/api/news?id=f087a6c6a6d6cfcabdcfb810056bf11ae98ef58c69a306cd2f63c8e75ef7e9b4",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1756335851,
      "headline": "Tracking Terry Smith's Fundsmith 13F Portfolio - Q2 2025 Update",
      "id": 136555000,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/538053368/image_538053368.jpg?io=getty-c-w1536",
      "related": "ADP",
      "source": "SeekingAlpha",
      "summary": "Read here for an in-depth analysis and insights on Fundsmith's $23.02B portfolio shift: new stakes, exits, and top positions like Meta and Microsoft.",
      "url": "https://finnhub.io/api/news?id=f087a6c6a6d6cfcabdcfb810056bf11ae98ef58c69a306cd2f63c8e75ef7e9b4"
    }
  },
  {
    "ts": null,
    "headline": "Pfizer: Finally Some Fortune, Plus Twenty High-Quality Dividend Growth Valuations",
    "summary": "Discover high-quality dividend-growth stocks near 52-week lows. Explore Pfizer's strong dividend and valuations, plus other top picks like Merck and Qualcomm.",
    "url": "https://finnhub.io/api/news?id=ec425284e980cf083d7d06feec4294590bc48a5d33b2fdd798c828b58de26570",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1756315645,
      "headline": "Pfizer: Finally Some Fortune, Plus Twenty High-Quality Dividend Growth Valuations",
      "id": 136542130,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2203006359/image_2203006359.jpg?io=getty-c-w1536",
      "related": "ADP",
      "source": "SeekingAlpha",
      "summary": "Discover high-quality dividend-growth stocks near 52-week lows. Explore Pfizer's strong dividend and valuations, plus other top picks like Merck and Qualcomm.",
      "url": "https://finnhub.io/api/news?id=ec425284e980cf083d7d06feec4294590bc48a5d33b2fdd798c828b58de26570"
    }
  },
  {
    "ts": null,
    "headline": "Best Dividend Aristocrats For September 2025",
    "summary": "Discover top Dividend Aristocrats for 2025! Explore undervalued picks with 10%+ annualized returns, robust payout growth, and reliable income opportunities.",
    "url": "https://finnhub.io/api/news?id=6fa72cb3c60dde4a3180ad17c2df91d58aa59ccc934dd1f72334c03464c353e0",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1756303789,
      "headline": "Best Dividend Aristocrats For September 2025",
      "id": 136539374,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1962656730/image_1962656730.jpg?io=getty-c-w1536",
      "related": "ADP",
      "source": "SeekingAlpha",
      "summary": "Discover top Dividend Aristocrats for 2025! Explore undervalued picks with 10%+ annualized returns, robust payout growth, and reliable income opportunities.",
      "url": "https://finnhub.io/api/news?id=6fa72cb3c60dde4a3180ad17c2df91d58aa59ccc934dd1f72334c03464c353e0"
    }
  }
]